Nanobiotix SA
PAR:NANO

Watchlist Manager

Nanobiotix SA

PAR:NANO

Watchlist

Dividends

Price: 3.626 EUR 4.56% Market Closed

Market Cap: 170.9m EUR

Have any thoughts about
Nanobiotix SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication

Add Price Alert

Price Target:

Last Price: 3.626 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

NANO Alert

Nanobiotix SA

3.626

+0.158 (+4.56%)

52 Week Range	2.706 6.79
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Nanobiotix SA

What unique competitive advantages
does Nanobiotix SA hold over its rivals?

What risks and challenges
does Nanobiotix SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Nanobiotix SA.

What unique competitive advantages
does Nanobiotix SA hold over its rivals?

What risks and challenges
does Nanobiotix SA face in the near future?

Has there been any significant insider trading activity
in Nanobiotix SA recently?

Summarize the latest earnings call
of Nanobiotix SA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Nanobiotix SA.

Provide P/S
for Nanobiotix SA.

Provide P/E
for Nanobiotix SA.

Provide P/OCF
for Nanobiotix SA.

Provide P/FCFE
for Nanobiotix SA.

Provide P/B
for Nanobiotix SA.

Provide EV/S
for Nanobiotix SA.

Provide EV/GP
for Nanobiotix SA.

Provide EV/EBITDA
for Nanobiotix SA.

Provide EV/EBIT
for Nanobiotix SA.

Provide EV/OCF
for Nanobiotix SA.

Provide EV/FCFF
for Nanobiotix SA.

Provide EV/IC
for Nanobiotix SA.

Show me price targets
for Nanobiotix SA made by professional analysts.

What are the Revenue projections
for Nanobiotix SA?

How accurate were the past Revenue estimates
for Nanobiotix SA?

What are the Net Income projections
for Nanobiotix SA?

How accurate were the past Net Income estimates
for Nanobiotix SA?

What are the EPS projections
for Nanobiotix SA?

How accurate were the past EPS estimates
for Nanobiotix SA?

What are the EBIT projections
for Nanobiotix SA?

How accurate were the past EBIT estimates
for Nanobiotix SA?

Compare the revenue forecasts
for Nanobiotix SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Nanobiotix SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Nanobiotix SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Nanobiotix SA compared to its peers.

Compare the P/E ratios
of Nanobiotix SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Nanobiotix SA with its peers.

Analyze the financial leverage
of Nanobiotix SA compared to its main competitors.

Show all profitability ratios
for Nanobiotix SA.

Provide ROE
for Nanobiotix SA.

Provide ROA
for Nanobiotix SA.

Provide ROIC
for Nanobiotix SA.

Provide ROCE
for Nanobiotix SA.

Provide Gross Margin
for Nanobiotix SA.

Provide Operating Margin
for Nanobiotix SA.

Provide Net Margin
for Nanobiotix SA.

Provide FCF Margin
for Nanobiotix SA.

Show all solvency ratios
for Nanobiotix SA.

Provide D/E Ratio
for Nanobiotix SA.

Provide D/A Ratio
for Nanobiotix SA.

Provide Interest Coverage Ratio
for Nanobiotix SA.

Provide Altman Z-Score Ratio
for Nanobiotix SA.

Provide Quick Ratio
for Nanobiotix SA.

Provide Current Ratio
for Nanobiotix SA.

Provide Cash Ratio
for Nanobiotix SA.

What is the historical Revenue growth
over the last 5 years for Nanobiotix SA?

What is the historical Net Income growth
over the last 5 years for Nanobiotix SA?

What is the current Free Cash Flow
of Nanobiotix SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Nanobiotix SA.

EV/EBITDA
Enterprise Value to EBITDA

-6.3

Current

-4.9

Median

3.9

Industry

Lower than median

Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA

-6.3

Enterprise Value

148.3m EUR

EBITDA

-23.5m EUR

All Countries

Forward Multiples

			Market Cap	EV/EBITDA
FR		Nanobiotix SA PAR:NANO	171.9m EUR	-6.3
FR		Pharnext SCA OTC:PNEXF	6T USD	-209 743.4
US		Abbvie Inc NYSE:ABBV	374.1B USD	17.3
US		Amgen Inc NASDAQ:AMGN	168.2B USD	16.6
US		Gilead Sciences Inc NASDAQ:GILD	131.1B USD	10.8
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	130.4B USD	27
US	E	Epizyme Inc F:EPE	94.1B EUR	-538.7
AU		CSL Ltd ASX:CSL	123.6B AUD	17.6
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	73B USD	11.1
US	S	Seagen Inc F:SGT	39.3B EUR	-61.6
NL		argenx SE XBRU:ARGX	34B EUR	332.7

				EBITDA Growth	EV/EBITDA to Growth
FR		Nanobiotix SA PAR:NANO	Average EV/EBITDA: 61.9 Negative Multiple: -6.3	N/A	N/A
FR		Pharnext SCA OTC:PNEXF	Negative Multiple: -209 743.4	N/A	N/A
US		Abbvie Inc NYSE:ABBV	17.3	13%	1.3
US		Amgen Inc NASDAQ:AMGN	16.6	14%	1.2
US		Gilead Sciences Inc NASDAQ:GILD	10.8	6%	1.8
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	27	16%	1.7
US	E	Epizyme Inc F:EPE	Negative Multiple: -538.7	N/A	N/A
AU		CSL Ltd ASX:CSL	17.6	12%	1.5
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	11.1	17%	0.7
US	S	Seagen Inc F:SGT	Negative Multiple: -61.6	N/A	N/A
NL		argenx SE XBRU:ARGX	332.7	168%	2

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/EBITDA

-3.3

2-Years Forward

EV/EBITDA

-2.8

3-Years Forward

EV/EBITDA

-5.9

	Franklin Covey Co NYSE:FC	28.68 USD -1.1%
	Mohawk Industries Inc NYSE:MHK	115.45 USD 0.82%
	Ardmore Shipping Corp NYSE:ASC	10.4709 USD -0.37%
	ASGN Inc NYSE:ASGN	65.21 USD -4.1%
	Skyworks Solutions Inc NASDAQ:SWKS	69 USD -1.5%
	Weatherford International PLC NASDAQ:WFRD	53.01 USD 0.38%

	Johnson & Johnson NYSE:JNJ	162.82 USD -0.1%
	Bank of America Corp NYSE:BAC	42.475 USD 0.63%
	Mastercard Inc NYSE:MA	537.3 USD 0.23%
	Salesforce Inc NYSE:CRM	279.005 USD -0.14%
	Abbvie Inc NYSE:ABBV	211.7 USD -0.26%
	Home Depot Inc NYSE:HD	355.99 USD 0.73%

	Arista Networks Inc NYSE:ANET	83.34 USD -1.28%
	Visa Inc NYSE:V	339.77 USD -0.03%
	Texas Pacific Land Corp NYSE:TPL	1 368.48 USD -1.19%
	KLA Corp NASDAQ:KLAC	712.11 USD -1.04%
	Manhattan Associates Inc NASDAQ:MANH	173.26 USD -0.7%
	Monolithic Power Systems Inc NASDAQ:MPWR	622.56 USD -1.16%

	ServiceNow Inc NYSE:NOW	821.61 USD -2.67%
	EOG Resources Inc NYSE:EOG	123.84 USD -0.88%
	Monster Beverage Corp NASDAQ:MNST	56.795 USD -0.04%
	Copart Inc NASDAQ:CPRT	53.8672 USD -0.02%
	Applied Materials Inc NASDAQ:AMAT	153.8 USD -0.43%
	Airbnb Inc NASDAQ:ABNB	126.415 USD 0.33%

Nanobiotix SA
PAR:NANO

EV/EBITDA
Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

Nanobiotix SA PAR:NANO

EV/EBITDA Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

Nanobiotix SA
PAR:NANO

EV/EBITDA
Enterprise Value to EBITDA